Theravance Biopharma (TBPH) Total Debt Growth (1y) (2019 - 2022)
Theravance Biopharma (TBPH) Total Debt Growth (1y) (2019 - 2022) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | 103.99% |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 3.84% |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 0.07% |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Theravance Biopharma | 864.82 Mn | 470.15 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2022 | 3.69% |
| Mar 31, 2022 | 1.64% |
| Dec 31, 2021 | -1.00% |
| Sep 30, 2021 | 0.94% |
| Jun 30, 2021 | 1.80% |
| Mar 31, 2021 | 3.47% |
| Dec 31, 2020 | 71.16% |
| Sep 30, 2020 | 66.65% |
| Jun 30, 2020 | 63.11% |
| Mar 31, 2020 | 62.76% |
| Dec 31, 2019 | -0.17% |